Vaccines
AssigneeSmithKline Beecham Biologicals s.a.
InventorsMartin Friede, Nathalie Garcon, Catherine Marie Ghislaine Gerard, Philippe Hermand
Life of this patent
Estimating the term…
Abstract
The present invention relates to adjuvant compositions which are suitable to be used in vaccines. In particular, the adjuvant compositions of the present invention comprises a saponin and an immunostimulatory oligonucleotide, optionally with a carrier. Also provided by the present invention are vaccines comprising the adjuvants of the present invention and an antigen. Further provided are methods of manufacture of the adjuvants and vaccines of the present invention and their use as medicaments. Methods of treating an individual susceptible to or suffering from a disease by the administration of the vaccines of the present invention are also provided.
Claims15
An adjuvant composition comprising a QS21 and an immunostimulatory oligonucleotide containing an unmethylated CG dinucleotide.
Dependencies are inferred from the claim text.